%0 Journal Article
%T Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210
%A Binghe Xu
%A Bo Lan
%A Dawei Wu
%A Dong Qu
%A Hongnan Mo
%A Hongtu Zhang
%A Jing Huang
%A Lanying Ma
%A Xi Wang
%A Xuelian Chen
%J Archive of "Cancer Biology & Medicine".
%D 2019
%R 10.20892/j.issn.2095-3941.2018.0172
%X SHR-1210 is a new and promising anti-PD-1 agent for solid tumors. During the phase I study of SHR-1210, we encountered a novel but prevalent immune-related dermatologic toxicity: reactive capillary hemangiomas (RCHs). Thus we tried to summarize the features of RCHs and estimate their relationship with tumor response
%K Reactive capillary hemangiomas
%K SHR-1210
%K skin toxicity
%K anti-tumor efficacy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528453/